Journal article
Trade Secrets: Promoting Innovation in Biosimilars
Australian Intellectual Property Journal, Vol.31(4), pp.262-279
2021
Abstract
Trade secrets are generally considered as stifling innovation, including the innovation of biosimilars. This article considers the alternative and suggests that trade secrets over biologics not only promote, but actually force biosimilar innovation. Specifically, trade secrets encourage biosimilars to innovate in two areas: process design and analytical science. Both areas of innovation are related to the unique nature of biologics and biosimilars and their molecular size, complexity and heterogeneity. However, it is not enough to say that the secret nature of originator manufacturing processes promotes innovation. This article will show that biosimilars may not only innovate in the sense of allowing cumulative innovation in analytical techniques for biopharmaceutical characterisation, but originator trade secrets also promote a different kind of innovation in biosimilar development processes: simultaneous innovation.
Details
- Title
- Trade Secrets: Promoting Innovation in Biosimilars
- Authors
- Teddy Henriksen (Author) - University of the Sunshine Coast, Queensland, School of Law and Society
- Publication details
- Australian Intellectual Property Journal, Vol.31(4), pp.262-279
- Publisher
- Lawbook Co.
- Organisation Unit
- School of Law and Society; University of the Sunshine Coast, Queensland; School of Business and Creative Industries
- Language
- English
- Record Identifier
- 99565408702621
- Output Type
- Journal article
Metrics
59 Record Views